| Not Yet Recruiting | Multi Interventional Approaches to Mitigate HIV Reservoirs Aiming the Sustained HIV Remission Without Antiretr NCT06805656 | Federal University of São Paulo | Phase 2 |
| Recruiting | Real World Use of Lenacapavir, as an add-on to an Optimized Background Regimen in France NCT06799338 | Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida | — |
| Recruiting | Impact of Pain From Injectables Antiretroviral Treatments in HIV-1 Patients Based on the Injection Site (Ventr NCT06834113 | Centre Hospitalier Régional d'Orléans | N/A |
| Not Yet Recruiting | The Expand Study-Pharmacist Administered Long Acting Cabotegravir + Rilpivirine to Expand Access for People Wi NCT06635421 | MetroHealth Medical Center | — |
| Unknown | Studying Topiramate for Re-Activating the HIV-1 Reservoir NCT06282783 | Erasmus Medical Center | Phase 1 / Phase 2 |
| Recruiting | Cervical Pre-cancer Treatment Failure Among Women Living With HIV in Zimbabwe NCT07202936 | University of Bern | — |
| Completed | Doravirine Versus Integrase Inhibitors on Backbone of Emtricitabine and Tenofovir Alafenamide in HIV NCT04820933 | University of Texas Southwestern Medical Center | EARLY_Phase 1 |
| Completed | ThiPhiSA: New Pathways to Prevention From Community TB Screening in South Africa NCT06214910 | University of Washington | N/A |
| Recruiting | Evaluating the Safety and Immunogenicity of MTBVAC NCT05947890 | HIV Vaccine Trials Network | Phase 2 |
| Terminated | Estradiol Therapy In Transgender Women to Research Interactions With HIV Therapy NCT06005610 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 |
| Completed | To Investigate Safety, Reactogenicity and Immunogenicity of VIR-1388 Compared With Placebo in Participants Wit NCT05854381 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Recruiting | Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis NCT05590455 | ANRS, Emerging Infectious Diseases | Phase 2 |
| Recruiting | Low Dose Nivolumab in Adults Living With HIV on Antiretroviral Therapy NCT05187429 | University of Melbourne | Phase 1 / Phase 2 |
| Completed | A Study Evaluating the Pharmacokinetics, Efficacy, Safety and Tolerability of CABENUVA NCT05601128 | Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) | Phase 3 |
| Active Not Recruiting | A Cohort Study of Use of Doravirine (DOR) Based Regimens in Clinical Practice in Europe DoRavirine Europe Real NCT05421806 | NEAT ID Foundation | — |
| Completed | The Visceral Adiposity Measurement and Observation Study NCT05383456 | Theratechnologies | — |
| Completed | Effect of a Mobile Health Intervention on Treatment Adherence NCT05187741 | Hospital Civil de Guadalajara | N/A |
| Unknown | Early Empiric Anti-Mycobacterium Tuberculosis Therapy for Sepsis in Sub-Saharan Africa NCT04618198 | University of Virginia | Phase 3 |
| Unknown | Neuroinflammation and Neurodegeneration in HIV-positive Subjects Switched and Initially Treated With INSTI NCT04887675 | University of Novi Sad | N/A |
| Active Not Recruiting | Intervention to Improve HIV Care Retention by Addressing Stigma Stigmatized Environments NCT05110963 | University of Connecticut | N/A |
| Completed | Assessing the Impact of INSTI to PI Switch on Insulin Sensitivity and Fat Metabolism NCT04675255 | Washington University School of Medicine | N/A |
| Completed | VIR-1111: A Prototype Human CMV-based Vaccine for Human Immunodeficiency Virus (HIV) in Healthy Volunteers NCT04725877 | Vir Biotechnology, Inc. | Phase 1 |
| Completed | Efficacy of Switching to DTG/3TC in Virologically-suppressed Adults Currently on B/F/TAF NCT04585737 | Charlotte-Paige Rolle, MD | Phase 4 |
| Completed | Acute Effects of TCIG vs ECIG in PLWH NCT04568395 | University of California, Los Angeles | N/A |
| Unknown | Leveraging Family-Based Assets for Black MSM In House Ball Communities NCT05071378 | State University of New York - Downstate Medical Center | N/A |
| Completed | Access HIV Ag/Ab Combo Assay - European Union (EU) Clinical Trial Protocol NCT04971343 | Beckman Coulter, Inc. | — |
| Completed | Evaluation of Pre-Exposure Prophylaxis (PrEP) in Pregnant and Breastfeeding Women NCT03902418 | University of California, Los Angeles | — |
| Unknown | Role of the IL33/Amphiregulin Pathway as a Potential Therapeutic Target in HIV Infection NCT03622177 | ANRS, Emerging Infectious Diseases | — |
| Completed | Charlotte Retention in Care Study NCT03584048 | Epividian | — |
| Completed | Community Based Antiretroviral Therapy (CBART) Among Children on Chronic ART NCT03986099 | Biomedical Research and Training Institute, Zimbabwe | N/A |
| Completed | Safety and Efficacy of Romidepsin and the Therapeutic Vaccine Vacc-4x for Reduction of the Latent HIV-1 Reserv NCT02092116 | Bionor Immuno AS | Phase 1 / Phase 2 |
| Completed | Immunogenicity Study of Vacc-4x Versus Placebo in Patients Infected With HIV NCT00659789 | Bionor Immuno AS | Phase 2 |